脑室内出血患者弥散张量成像系列变化与脑室血清除速率
该研究对26例脑出血伴脑室内出血患者在发病第1、14、28、42天进行磁共振成像,测量血肿体积、脑室血体积及同侧脑室脑脊液弥散指标FA和MD,其中14例接受脑室外引流。结果显示血肿体积日清除率2.1%、脑室血体积日清除率1.3%;同侧脑室FA每日下降1.3%、MD每日升高1.5%(后验概率均>99%)。脑室血体积与NIHSS评分强相关(后验概率97-99%),MD变化与脑室血体积相关。作者认为vFA和vMD可能作为脑室血状态的生物标志物。
要点
- 26例脑出血伴脑室内出血患者中,血肿体积日清除率为2.1%,脑室血体积日清除率为1.3%。
- 同侧脑室FA每日下降1.3%、MD每日升高1.5%,后验概率均>99%。
- 接受脑室外引流的14例患者vFA下降更快(1.5% vs. 1.1%/天)、vMD升高更快(1.8% vs. 1.5%/天)。
- 脑室血体积每增加1.00 cm3,vMD降低5.2%(后验概率<99%);脑室血体积与NIHSS评分强相关(后验概率97-99%)。
- 作者认为vFA和vMD可能作为脑室血状态的生物标志物。
适用人群与场景
- 脑出血并扩展至脑室的脑室内出血患者,共26例;其中14例接受脑室外引流。
- 在发病第1、14、28、42天进行磁共振成像。
研究设计与关键结果
- 研究类型为影像学队列研究,纳入26例脑出血伴脑室内出血患者,在发病第1、14、28、42天行磁共振成像,测量血肿体积、脑室血体积及同侧脑室脑脊液FA和MD;14例接受脑室外引流;采用广义线性混合模型统计分析。
- 第1天平均血肿体积为14.6 ± 16.7 cm3,平均NIHSS评分为16 ± 8。
- 血肿体积日清除率为2.1%,脑室血体积日清除率为1.3%。
- 同侧脑室FA每日下降1.3%(后验概率>99%),同侧脑室MD每日升高1.5%(后验概率>99%)。
- 接受脑室外引流患者vFA下降1.5%/天 vs. 未接受脑室外引流患者1.1%/天;vMD升高1.8%/天 vs. 1.5%/天。
- 脑室血体积每增加1.00 cm3,vMD降低5.2%(后验概率<99%);脑室血体积与NIHSS评分强相关(后验概率97-99%)。
- 脑脊液引流量较大与vFA下降更大相关(后验概率83.4%);引流量较小与vMD升高更大相关(后验概率94.8%)。
证据类型、等级与局限
- 证据类型:影像学队列研究(26例,其中14例接受脑室外引流)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为vFA和vMD可能作为脑室血状态的生物标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: We developed a noninvasive biomarker to quantify the rate of ventricular blood clearance in patients with intracerebral hemorrhage and extension to the ventricles-intraventricular hemorrhage.
METHODS: We performed magnetic resonance imaging in 26 patients at 1, 14, 28, and 42 days of onset and measured their hematoma volume (HV), ventricular blood volume (VBV), and two diffusion metrics: fractional anisotropy (FA), and mean diffusivity (MD). The ipasilesional ventricular cerebral spinal fluid's FA and MD were associated with VBV and stroke severity scores (National Institute of Health Stroke Scale [NIHSS]). A subcohort of 14 patients were treated with external ventricular drain (EVD). A generalized linear mixed model was applied for statistical analysis.
RESULTS: At day 1, the average HVs and NIHSS scores were 14.6 ± 16.7 cm3 and 16 ± 8, respectively. A daily rate of 2.1% and 1.3% blood clearance/resolution were recorded in HV and VBV, respectively. Ipsilesional ventricular FA (vFA) and ventricular MD (vMD) were simultaneously decreased (vFA = 1.3% per day, posterior probability [PP] > 99%) and increased (vMD = 1.5% per day, PP > 99%), respectively. Patients with EVD exhibited a faster decline in vFA (1.5% vs. 1.1% per day) and an increase in vMD (1.8% vs. 1.5% per day) as compared with patients without EVD. Temporal change in vMD was associated with VBV; a 1.00-cm3 increase in VBV resulted in a 5.2% decrease in vMD (PP < 99%). VBV was strongly associated with NIHSS score (PP = 97-99%). A larger cerebral spinal fluid drained volume was associated with a greater decrease (PP = 83.4%) in vFA, whereas a smaller volume exhibited a greater increase (PP = 94.8%) in vMD.
CONCLUSIONS: In conclusion, vFA and vMD may serve as biomarkers for VBV status.
参考来源
- Vyas V, Savitz SI, Boren SB, et al. Serial Diffusion Tensor Imaging and Rate of Ventricular Blood Clearance in Patients with Intraventricular Hemorrhage. Neurocrit Care. 2024. PMID: 39085503. doi:10.1007/s12028-024-02070-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。